Anfield Resources 28,880,615-share private placement
Anfield Resources 28,880,615-share private placement
Momentum Public Relations
Press Release: March 6, 2017
The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement announced on Feb. 21, 2017.
Number of shares: 28,880,615 shares
Purchase price: 10 cents per share
Warrants: 28,880,615 share purchase warrants to purchase 28,880,615 shares
Warrant exercise price: 20 cents for a two-year period
Number of placees: 38 placees
Insiders: Laara Shaffer, 200,000 shares; Corey Dias, two million shares; Joshua Bleak, 750,000 shares
Finders’ fees: Leede Jones Gable Inc., $11,550 and 115,500 warrants that are exercisable into common shares at 20 cents per share for a 24-month period; Gravitas Securities Inc., $3,500 and 35,000 warrants that are exercisable into common shares at 20 cents per share for a 24-month period; Canaccord Genuity Corp., $7,000 and 70,000 warrants that are exercisable into common shares at 20 cents per share for a 24-month period
Pursuant to Corporate Finance Policy 4.1, Section 1.11(d), the company issued a news release dated March 6, 2017, announcing the closing of the private placement and setting out the expiry dates of the hold period(s). Note that in certain circumstances the exchange may later extend the expiry date of the warrants if they are less than the maximum permitted term.
© 2017 Canjex Publishing Ltd. All rights reserved.
- Published in Anfield Resources, Mining, News Home
Majescor arranges $1-million private placement
Majescor arranges $1-million private placement
– Momentum Public Relations –
Press Release: February 15, 2017
Majescor Resources Inc. has arranged a $1-million non-brokered private placement composed of 10 million units at 10 cents per unit with one common share purchase warrant. Each warrant entitles the holder thereof to acquire one additional common share in the capital of the corporation at a price of 16 cents per common share for a period of 24 months following the closing of the offering. The warrants carry a forced exercise provision that, should the corporation’s common shares trade at a price of 24 cents or more for 30 consecutive days, the warrantholder will then have 30 days following the 30th day of trading to exercise the warrants before they expire. All securities issued in the private placement are subject to a four-month hold period. The proceeds of the financing will be used for exploration and working capital.
The corporation may pay finders’ fees on a portion of the private placement not relating to insiders of the corporation.
About Majescor Resources Inc.
Majescor is a junior mining exploration company with an extensive portfolio of gold and diamond properties in Quebec.
© 2017 Canjex Publishing Ltd. All rights reserved.
- Published in Albert Mining, Mining, News Home
Sirona Biochem Announces Convertible Note Financing
VANCOUVER, BC–(Marketwired – January 31, 2017) – Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) (XETRA: ZSB) announced today a non-brokered private placement (the “Private Placement”) of convertible notes (“Notes”) for gross proceeds of up to $600,000. Each Note will be convertible at the option of the holder into one common share of the company at a conversion price of $0.18 per share during the 18 month term of the Notes.
The Notes will mature in 18 months from the date of issuance and bear interest at the rate of 12{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} per annum, payable quarterly, until the Notes are converted or repaid. The company will be entitled to repay the principal amount of the Notes, together with accrued and unpaid interest, at any time commencing four months after the date of issuance, subject to giving the holders prior notice thereof to permit holders to convert during the notice period. The Notes are unsecured and transferable, subject to resale restrictions under applicable securities laws and TSX Venture Exchange requirements.
Sirona Biochem intends to use the net proceeds from the Private Placement for general working capital, and to support the company’s efforts to secure a licensing agreement for its skin lightening compound, TFC-1067. The company is expecting to receive a term sheet for a licensing transaction for TFC-1067 in Q1 2017 but there can be no assurances that a licensing agreement will be entered into on terms acceptable to Sirona Biochem or at all. The Company may pay fees of 7{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} in cash to qualified finders.
All securities issued in connection with the private placement will be subject to a statutory hold period of four months commencing from the date of issuance of the Notes. Closing of the private placement is subject to customary conditions, including TSX Venture Exchange acceptance.
This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the Shares in any jurisdiction in which such offer, solicitation or sale would be unlawful. The Shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to, or for the benefit of, U.S. persons (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.
In addition, the Company announces an extension to the term of 8,865,970 common share purchase warrants (the “Warrants”) originally issued on March 6, 2014. The warrants were issued as part of a private placement. The expiry dates will be extended as follows:
March 6, 2014
Number of Warrants: | 8,865,970 |
Original Expiry Date of Warrants: | March 6, 2017 |
New Expiry Date of Warrants: | April 30, 2017 |
Exercise Price of Warrants: | $0.20 |
All other terms of the Warrants will remain unchanged.
About Sirona Biochem Corp.
Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential.
Sirona’s compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and ongoing royalty payments. Sirona’s laboratory, TFChem, is located in France and is the recipient of multiple French national scientific awards and European Union and French government grants. For more information, please visit www.sironabiochem.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Sirona Biochem cautions you that statements included in this press release that are not a description of historical facts may be forward-looking statements. Forward-looking statements are only predictions based upon current expectations and involve known and unknown risks and uncertainties. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of release of the relevant information, unless explicitly stated otherwise. Actual results, performance or achievement could differ materially from those expressed in, or implied by, Sirona Biochem’s forward-looking statements due to the risks and uncertainties inherent in Sirona Biochem’s business including, without limitation, statements about: a third party potential licensees of TFC-1067 may not deliver a term sheet to the company in Q1 2017 or at all; the company may not be able to negotiate a license agreement with a potential licensees of TFC-1067 on terms acceptable to Sirona Biochem; the progress and timing of its clinical trials are uncertain; difficulties or delays in development, testing, obtaining regulatory approval, producing and marketing products; unexpected adverse side effects or inadequate therapeutic efficacy of the company’s or licensed products that could delay or prevent product development or commercialization; the scope and validity of patent protection for the company’s or licensed products; competition from other pharmaceutical or biotechnology companies; and its ability to obtain additional financing to support its operations. Sirona Biochem does not assume any obligation to update any forward-looking statements except as required by law.
CONTACT INFORMATION
-
For more information regarding this press release, please contact:
Christopher Hopton
CFO
Sirona Biochem Corp.
Phone: 1.604.282.6064
Email: chopton@sironabiochem.com
- Published in Bio technology, News Home, Sirona Biochem
Majescor Resources 416,666-share private placement
Majescor Resources 416,666-share private placement
– Momentum Public Relations –
Press Release: January 25, 2017
The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement announced Jan. 4, 2017.
Number of shares: 416,666 flow-through shares
Purchase price: 12 cents per share
Number of placees: one placee
For further details, please refer to the company’s news release dated Jan. 4, 2017.
© 2017 Canjex Publishing Ltd. All rights reserved.
- Published in Albert Mining, Mining, News Home
Klondike Silver Announces Private Placement 17.01.17
Vancouver, Canada / TheNewswire / January 17, 2017 – Klondike Silver Corp. (the “Company”) (TSX.V: KS) announces that it is raising up to $1,000,000 through a non-brokered private placement (the “Private Placement”) of up to 20,000,000 units at a price of $0.05 per unit. Each unit will consist of one common share and one non-transferable share purchase warrant, with each warrant exercisable for a period of five years from the closing at a price of $0.05 per share. All Units are subject to a four-month hold period from the date of issuance. Commissions may be paid on a portion of the funds raised.
Completion of the Private Placement is subject to the approval of the TSX Venture Exchange.
The net proceeds will be used for advancing the Sandon B.C. project, located 80 KM north of the Trail B.C. smelter, and for general working capital.
For additional information please visit the company website www.klondikesilver.com .
CONTACT INFORMATION
Corporate Inquiries:
Dale Dobson: (604) 682.2928
Email: dale.dobson@klondikesilver.com
On Behalf of the Board of Directors
Klondike Silver Corp.
Thomas Kennedy CEO
“Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.”
Suite 804 – 750 West Pender Street T: 604.682.2928
Vancouver, B.C., V6C 2T7 Canada F: 604.685.6905
www.KlondikeSilver.com TSXV: KS / FSE: K1SN
Copyright (c) 2017 TheNewswire – All rights reserved.
- Published in Klondike Silver Corp., Mining, News Home
Arctic Star 22.46-million-share private placement
The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement announced on Oct. 12, 2016.
Number of shares: 22.46 million shares
Purchase price: six cents per share
Warrants: 22.46 million share purchase warrants to purchase 22.46 million shares
Warrant initial exercise price: eight cents
Warrant term to expiry: two years
Number of placees: 36 placees
Insiders: B.J. Financial Accounting Consultants Inc. (Brijender Jassal), 500,000 shares; 0800025 B.C. Ltd. (Patrick Power), 3.75 million shares; Thomas Yingling, one million shares; Lithosphere Services Inc. (Buddy Doyle), 2.45 million shares; William Ferreira, one million shares
Aggregate pro group involvement: 550,000 shares (two placees)
Finders’ fees: Canaccord Genuity Corp., $21,600 cash, 760,000 warrants; PI Financial Corp., $3,600 cash
Finder warrant initial exercise price: six cents
Finder warrant term to expiry: Each warrant is exercisable into one share at six cents per share until Dec. 29, 2018.
Note that in certain circumstances the exchange may later extend the expiry date of the warrants if they are less than the maximum permitted term.
© 2017 Canjex Publishing Ltd. All rights reserved.
- Published in Arctic Star Exploration, Mining, News Home
King’s Bay Gold Corporation Announces Closing of Private Placement 3.01.17
January 3, 2017 – King’s Bay Gold Corporation (the “Company”) (TSXV: KBG) is pleased to announce that it has completed a non-brokered private placement (the “Financing”) of 12,516,700 units (each, a “Unit”) at a price of $0.075 per Unit for gross proceeds of $938,752.50. Each Unit consists of one common share of the Company and one non-transferable common share purchase warrant (each, a “Warrant”). Each Warrant will entitle the holder thereof to acquire one common share (each, a “Warrant Share”) of the Company at a price of $0.12 per Warrant Share for a period of 2 years from the closing of the Financing.
In connection with the Financing, the Company paid cash finder’s fees of $6,600 and issued 33,600 shares and 33,600 share purchase warrants (the “Finder’s Warrants”) to certain finders. The Finder’s Warrants have the same terms as the Warrants.
The Company intends to use the proceeds of the Offering as follows: $100,000 G & A, $90,000 salaries, $100,000 corporate development, $50,000 legal, accounting and regulatory fees, property acquisition costs $100,000, travel and promotion $60,000 unallocated working capital $100,000, and exploration expenditures of $500,000.
All securities issued in connection with the Financing are subject to a statutory hold period expiring four months and one day after the closing of the Financing. Insiders of the Company subscribed for an aggregate of 373,333 Units under the Financing, which is a “related party transaction” within the meaning of Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The participation of the insider in the private placement was exempt from the valuation and minority shareholder approval requirements of MI 61-101 by virtue of the exemptions contained in Sections 5.5(a) and 5.7(a) of MI 61-101 in that the fair market value of the consideration of the shares to be issued to the insider did not exceed 25{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} of the Company’s market capitalization. None of the securities issued in connection with the financing will be registered under the United States Securities Act of 1933, as amended (the “1933 Act”), and none of them may be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act. This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there by any sale of the securities in any state where such offer, solicitation, or sale would be unlawful.
ON BEHALF OF THE BOARD OF DIRECTORS
King’s Bay Gold Corporation
Kevin Bottomley
President and Chief Executive Officer
Tel: (604) 681-1568 Email: Kevin@kingsbayres.com
For investment inquiries please contact Brad Hoeppner Director Tel: (604) 681-1568 Email: Brad@kingsbayres.com
Neither TSX Venture Exchange Inc. nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange Inc.) accepts responsibility for the adequacy or accuracy of this release.
© 2017 Canjex Publishing Ltd. All rights reserved.
- Published in King's Bay, Mining, News Home
Sage Gold Inc. (SGX:tsxv) Amends Terms of Hard Dollar Private Placement
Sage Gold Inc. Amends Terms of Hard Dollar Private Placement
– Momentum Public Relations –
Press Release: December 21, 2016
Sage Gold Inc. (the “Corporation”) (TSX VENTURE:SGX) announces that it has amended the terms of the Hard Dollar unit as previously announced on December 6th, 2016. The Hard Dollar unit will be priced at $0.11 per Unit versus the previous price of $0.12 per unit. The terms of the half warrant associated with the Hard Dollar unit and the flow through shares remain unchanged. Refer to the press release of December 6th.
Securities issued pursuant to the Offering shall be subject to a four-month hold period commencing on the Closing Date under applicable Canadian securities laws. The Corporation intends to use the net proceeds from the flow through share Offering to incur Canadian Exploration Expenses (CEE) on its eligible projects and the proceeds of the Hard Dollar Units for general working capital purposes.
The Offering is subject to certain conditions including, but not limited to, the receipt of all necessary approvals including the approval of the TSX Venture Exchange and the securities regulatory authorities.
The Company is a mineral exploration and development company which has primary interests in near-term production and exploration properties in Ontario. Its main properties are the 100{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} Clavos Gold property in Timmins and the 100{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} owned Onaman property including the Lynx copper, gold, silver property and other exploration properties in the Beardmore-Geraldton Gold Camp. Technical reports and information relating to the properties can be obtained from the System for Electronic Document Analysis and Retrieval (SEDAR) website at www.sedar.com and www.sagegoldinc.com.
Sage Gold Inc. Announces Non-Brokered Private Placement
Sage Gold Inc. Announces Non-Brokered Private Placement
– Momentum Public Relations –
Press Release: December 06, 2016
Sage Gold Inc. (the “Corporation”) (TSX VENTURE:SGX) is pleased to announce that it intends to complete a non-brokered private placement (the “Offering”), subject to regulatory approval. The Offering will consist of the sale of 8 million Hard Dollar Units (“HD Units”) at $0.12 per HD Unit and 6 million Flow-Through shares (“FT shares”) at $0.14 per FT share. Each HD Unit includes one Common Share of the Corporation plus one half (1/2) of one Common Share purchase warrant (each whole warrant, a “Warrant”) for gross proceeds of Cdn$960,000. Each full Warrant entitles its holder to purchase one Common Share (a “Warrant Share”) at an exercise price of $0.24 for a period of 24 months following the Closing Date, whereupon the Warrants will expire. Each Flow-Thorough common share will be issued on a flow-through basis. Total proceeds of the FT shares will be Cdn$840,000. Eligible finders may receive cash and / or compensation shares up to 10{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} of the Offering.
If the Corporation’s shares trade at or above $0.35 per share for 20 consecutive trading days, the Corporation may, at any time after the expiry of the statutory hold period, accelerate the expiration of the Warrants upon not less than 30 days written notice by the Corporation, and thereafter repurchase any unexercised Warrants at $0.001 per underlying common share.
The Corporation may at its discretion sell additional common share units or flow-through shares to raise additional proceeds of up to twenty-five per cent (25{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce}) of the Gross Proceeds of the Offerings.
Securities issued pursuant to the Offering shall be subject to a four-month hold period commencing on the Closing Date under applicable Canadian securities laws. The Corporation intends to use the net proceeds from the FT share Offering to incur Canadian Exploration Expenses (CEE) on its eligible projects and the proceeds of the HD Units for general working capital purposes.
The Offering is subject to certain conditions including, but not limited to, the receipt of all necessary approvals including the approval of the TSX Venture Exchange and the securities regulatory authorities.
The Company is a mineral exploration and development company which has primary interests in near-term production and exploration properties in Ontario. Its main properties are the 100{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} Clavos Gold property in Timmins and the 100{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} owned Onaman property including the Lynx copper, gold, silver property and other exploration properties in the Beardmore-Geraldton Gold Camp. Technical reports and information relating to the properties can be obtained from the System for Electronic Document Analysis and Retrieval (SEDAR) website at www.sedar.com and www.sagegoldinc.com.
Tetra Bio-Pharma (TBP:CSE) Receives $1,000,000 Investment from Aphria
Aphria Makes $1,000,000 Investment in Tetra Bio-Pharma via Private Placement to Fund PhytoPain Pharma Clinical Trials
– Momentum Public Relations –
Press Releases: December 6, 2016
Tetra Bio-Pharma Inc. (“Tetra Bio” or “the Company”) (CSE:TBP)(CSE:TBP.CN) and (OTC PINK:GRPOF) is conducting a non-brokered private placement with Aphria Inc. (TSX VENTURE:APH)(OTCQB:APHQF) of 5,000,000 units at a price of $0.20 per unit for aggregate gross proceeds of $1,000,000. Each unit will consist of one common share and one non-transferable warrant, with a whole warrant entitling the holder to purchase one common share of the Company at a price of $0.26 per share for a period of 3 years following the closing date. The warrants are subject to an accelerated expiry if the Company’s shares trade above $0.45 for thirty (30) consecutive trading days then the warrants will expire in 30 days if not exercised.
The private placement closed on December 5, 2016.
Completion of the private placement is subject to the receipt of all necessary regulatory approvals, including the approval of the Exchange.
The securities issued pursuant to the private placement will be subject to a four-month hold period from the closing date.
The proceeds of the private placement will be used to initiate clinical trials in PhytoPain Pharma Inc.
“Obtaining an investment from one of Canada’s leading cannabis producers re-enforces the value of the research and development being conducted by the science team at Tetra Bio-Pharma lead by Chief Science Officer, Dr. Guy Chamberland,” commented Ryan Brown, Co-Founder/VP Business Development.
- Published in News Home, Tetra Bio Pharma